Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model
- PMID: 17048504
- DOI: 10.1166/jnn.2006.425
Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model
Abstract
Wheat germ agglutinin (WGA) modified liposomes and solid lipid nanoparticles (SLNs) were evaluated for improving intestinal absorption of insulin. In an in situ local intestinal perfusion experiment, formulations containing 100 IU/kg insulin were administered to the duodenum, jejunum, and ileum of fasted rats. As hypothesized, ileum was the best intestinal location for the absorption of insulin-containing liposomes. Serum insulin concentrations decreased for the various formulations in different absorption sites according to the following trends: Duodenum > ileum > jejunum for WGA-modified insulin-containing liposomes; duodenum > jejunum > ileum for WGA-modified insulin-containing SLNs; ileum > jejunum > duodenum for insulin-containing liposomes; ileum > duodenum > jejunum for insulin-containing SLNs; and duodenum > or = ileum > jejunum for aqueous solution of insulin. These results imply that the nanoparticle type and delivery site were important factors with respect to increasing the bioavailability of insulin following oral administration. The proteolytic degradation as well as the epithelial permeability were primary determinants influcing insulin mucosal absorption.
Similar articles
-
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.Int J Pharm. 2006 Dec 11;327(1-2):153-9. doi: 10.1016/j.ijpharm.2006.07.026. Epub 2006 Jul 21. Int J Pharm. 2006. PMID: 16935443
-
Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats.J Drug Target. 2002 May;10(3):255-60. doi: 10.1080/10611860290022688. J Drug Target. 2002. PMID: 12075827
-
Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.Drug Deliv. 2014 Aug;21(5):370-8. doi: 10.3109/10717544.2014.905653. Epub 2014 May 6. Drug Deliv. 2014. PMID: 24797098
-
Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles.J Drug Target. 2020 Nov;28(9):882-903. doi: 10.1080/1061186X.2020.1759078. Epub 2020 Apr 29. J Drug Target. 2020. PMID: 32310678 Review.
-
Drug delivery to the intestinal lymph by oral formulations.Pharm Dev Technol. 2022 Feb;27(2):175-189. doi: 10.1080/10837450.2022.2030353. Epub 2022 Feb 8. Pharm Dev Technol. 2022. PMID: 35037843 Review.
Cited by
-
Solid Lipid Nanoparticles for Duodenum Targeted Oral Delivery of Tilmicosin.Pharmaceutics. 2020 Aug 4;12(8):731. doi: 10.3390/pharmaceutics12080731. Pharmaceutics. 2020. PMID: 32759764 Free PMC article.
-
Effects of engineered nanomaterials on plants growth: an overview.ScientificWorldJournal. 2014;2014:641759. doi: 10.1155/2014/641759. Epub 2014 Aug 14. ScientificWorldJournal. 2014. PMID: 25202734 Free PMC article. Review.
-
Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.AAPS PharmSciTech. 2011 Mar;12(1):62-76. doi: 10.1208/s12249-010-9563-0. Epub 2010 Dec 21. AAPS PharmSciTech. 2011. PMID: 21174180 Free PMC article. Review.
-
Phospholipids and lipid-based formulations in oral drug delivery.Pharm Res. 2010 Aug;27(8):1469-86. doi: 10.1007/s11095-010-0130-x. Epub 2010 Apr 22. Pharm Res. 2010. PMID: 20411409 Review.
-
Basics and recent advances in peptide and protein drug delivery.Ther Deliv. 2013 Nov;4(11):1443-67. doi: 10.4155/tde.13.104. Ther Deliv. 2013. PMID: 24228993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials